Advertisement

Sports Medicine

, Volume 39, Issue 10, pp 813–832 | Cite as

Caffeine and Anaerobic Performance

Ergogenic Value and Mechanisms of Action
  • J. K. Davis
  • J. Matt Green
Review Article

Abstract

The effect caffeine elicits on endurance performance is well founded. However, comparatively less research has been conducted on the ergogenic potential of anaerobic performance. Some studies showing no effect of caffeine on performance used untrained subjects and designs often not conducive to observing an ergogenic effect. Recent studies incorporating trained subjects and paradigms specific to intermittent sports activity support the notion that caffeine is ergogenic to an extent with anaerobic exercise. Caffeine seems highly ergogenic for speed endurance exercise ranging in duration from 60 to 180 seconds. However, other traditional models examining power output (i.e. 30-second Wingate test) have shown minimal effect of caffeine on performance. Conversely, studies employing sport-specific methodologies (i.e. hockey, rugby, soccer) with shorter duration (i.e. 4–6 seconds) show caffeine to be ergogenic during high-intensity intermittent exercise. Recent studies show caffeine affects isometric maximal force and offers introductory evidence for enhanced muscle endurance for lower body musculature. However, isokinetic peak torque, one-repetition maximum and muscular endurance for upper body musculature are less clear. Since relatively few studies exist with resistance training, a definite conclusion cannot be reached on the extent caffeine affects performance.

It was previously thought that caffeine mechanisms were associated with adrenaline (epinephrine)-induced enhanced free-fatty acid oxidation and consequent glycogen sparing, which is the leading hypothesis for the ergogenic effect. It would seem unlikely that the proposed theory would result in improved anaerobic performance, since exercise is dominated by oxygen-independent metabolic pathways. Other mechanisms for caffeine have been suggested, such as enhanced calcium mobilization and phosphodiesterase inhibition. However, a normal physiological dose of caffeine in vivo does not indicate this mechanism plays a large role. Additionally, enhanced Na+/K+ pump activity has been proposed to potentially enhance excitation contraction coupling with caffeine. A more favourable hypothesis seems to be that caffeine stimulates the CNS. Caffeine acts antagonistically on adenosine receptors, thereby inhibiting the negative effects adenosine induces on neurotransmission, arousal and pain perception. The hypoalgesic effects of caffeine have resulted in dampened pain perception and blunted perceived exertion during exercise. This could potentially have favourable effects on negating decreased firing rates of motor units and possibly produce a more sustainable and forceful muscle contraction. The exact mechanisms behind caffeine’s action remain to be elucidated.

Keywords

Caffeine Resistance Training Maximal Voluntary Contraction Bench Press Trained Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content if this review.

References

  1. 1.
    Graham TE. Caffeine and exercise: metabolism, endurance and performance. Sports Med 2001; 31: 785–807PubMedCrossRefGoogle Scholar
  2. 2.
    Spriet LL. Caffeine and performance. Int J Sport Nutr 1995; 5 Suppl.: S84–99Google Scholar
  3. 3.
    Magkos F, Kavouras SA. Caffeine and ephedrine: physiological, metabolic and performance enhancing effects. Sports Med 2004; 34: 871–89PubMedCrossRefGoogle Scholar
  4. 4.
    Sinclair CJ, Geiger JD. Caffeine use in sports: a pharmacological review. J Sports Med Phys Fitness 2000; 40: 71–9PubMedGoogle Scholar
  5. 5.
    Keisler BD, Armsey TD. Caffeine as an ergogenic aid. Curr Sports Med Rep 2006; 5: 215–9PubMedGoogle Scholar
  6. 6.
    Paluska SA. Caffeine and exercise. Curr Sports Med Rep 2003; 2: 213–9PubMedGoogle Scholar
  7. 7.
    Doherty M, Smith PM. Effects of caffeine ingestion on exercise testing: a meta-analysis. Int J Sport Nutr Exerc Metab 2004; 14: 626–46PubMedGoogle Scholar
  8. 8.
    Doherty M, Smith PM. Effects of caffeine ingestion on rating of perceived exertion during and after exercise:a meta-analysis. Scand J Med Sci Sports 2005; 15: 69–78PubMedCrossRefGoogle Scholar
  9. 9.
    Inbar O, Bar-or O, Skinner JS. The Wingate anaerobic test. Champaign (IL): Human Kinetics, 1996Google Scholar
  10. 10.
    Smith JC, Hill DW. Contribution of energy systems during a Wingate power test. Br J Sports Med 1991; 25: 196–9PubMedCrossRefGoogle Scholar
  11. 11.
    Medbø JI, Gramvik P, Jebens E. Aerobic and anaerobic energy release during 10 and 30s bicycle sprints. Acta Kinesiol Univ Tartuensis 1999; 4: 122–46Google Scholar
  12. 12.
    Medbø JI, Tabata I. Relative importance of aerobic and anaerobic energy release during short-lasting exhaustingbicycle exercise. J Appl Physiol 1989; 67: 1881–6PubMedGoogle Scholar
  13. 13.
    Withers RT, Sherman WM, Clark DG, et al. Muscle metabolism during 30, 60, and 90s of maximal cycling on anair-braked ergometer. Eur J Appl Physiol 1991; 63: 354–62CrossRefGoogle Scholar
  14. 14.
    Collomp K, Ahmaidi S, Audran M, et al. Effects of caffeine ingestion on performance and anaerobic metabolismduring the Wingate test. Int J Sports Med 1991; 12: 439–43PubMedCrossRefGoogle Scholar
  15. 15.
    Bell DG, Jacobs I, Ellerington K. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exercise 2001; 33: 1399–403CrossRefGoogle Scholar
  16. 16.
    Beck TW, Joush TJ, Schmidit RJ, et al. The acute effects of caffeine-containing supplement on strength, muscle endurance,and anaerobic capabilities. J Strength Cond Res 2006; 20: 506–10PubMedGoogle Scholar
  17. 17.
    Greer F, McLean C, Graham TE. Caffeine, performance and metabolism during repeated Wingate exercise test. J Appl Physiol 1998; 85: 1502–8PubMedGoogle Scholar
  18. 18.
    Greer F, Morales J, Coles M. Wingate performance and surface EMG frequency variables are not affected by caffeineingestion. Appl Physiol Nutr Metab 2006; 31: 597–603PubMedCrossRefGoogle Scholar
  19. 19.
    Williams JH, Signorile JF, Barnes WS, et al. Caffeine, maximal power output and fatigue. Br J Sports Med 1988; 22: 132–4PubMedCrossRefGoogle Scholar
  20. 20.
    Lorino AJ, Lloyd LK, Crixell SH, et al. The effects of caffeine on athletic agility. J Strength Cond Res 2006; 20: 851–4PubMedGoogle Scholar
  21. 21.
    Hoffman JR, Kang J, Ratamess NA, et al. Effect of nutritionally enriched coffee consumption on aerobic andanaerobic exercise performance. J Strength Cond Res 2007; 21: 456–9PubMedGoogle Scholar
  22. 22.
    Roberts MD, Taylor LW, Wismann JA, et al. Effects of ingesting JavaFit Energy Extreme functional coffee onaerobic and anaerobic fitness markers in recreationally active coffee consumers. J Int Soc Sports Nutr 2007; 4: 25PubMedCrossRefGoogle Scholar
  23. 23.
    Kang H, Kim H, Kim B. Acute effects of caffeine intake on maximal anaerobic power during the 30s Wingate cyclingtest [abstract]. J Exerc Physiol Online 1998; 1 (3)Google Scholar
  24. 24.
    Cox GR, Desbrow B, Montgomery PG, et al. Effect of different protocols of caffeine intake on metabolism andendurance performance. J Appl Physiol 2002; 93: 990–9PubMedGoogle Scholar
  25. 25.
    Kovacs EM, Stegen JHCH, Brouns F. Effect of caffeinated drinks on substrate metabolism, caffeine excretion, andperformance. J Appl Physiol 1998; 85: 709–15PubMedGoogle Scholar
  26. 26.
    Spencer M, Bishop D, Dawson B, et al. Physiological and metabolic responses of repeated-sprint activities: specificto field-based team sports. Sports Med 2005; 35: 1025–44PubMedCrossRefGoogle Scholar
  27. 27.
    Schneiker KT, Bishop D, Dawson B, et al. Effects of caffeine on prolonged intermittent-sprint ability in teamsportathletes. Med Sci Sports Exerc 2006; 38: 578–85PubMedCrossRefGoogle Scholar
  28. 28.
    Anselm F, Collomp K, Mercier B, et al. Caffeine increases maximal anaerobic power and blood lactate concentration. Eur J Appl Physiol 1992; 65: 188–91CrossRefGoogle Scholar
  29. 29.
    Paton CD, Hopkins WG, Vollebreght L. Little effect of caffeine ingestion on repeated sprints in team-sport athletes. Med Sci Sports Exerc 2001; 33: 822–5PubMedGoogle Scholar
  30. 30.
    Stuart GR, Hopkins WG, Cook C, et al. Multiple effects of caffeine on simulated high-intensity team-sport performance. Med Sci Sports Exerc 2005; 37: 1998–2005PubMedCrossRefGoogle Scholar
  31. 31.
    Collomp K, Ahmaidi S, Chatard JC, et al. Benefits of caffeine ingestion on sprint performance in trained and untrainedswimmers. Eur J Appl Physiol 1992; 64: 377–80CrossRefGoogle Scholar
  32. 32.
    Doherty M. The effects of caffeine on the maximal accumulated oxygen deficit and short-term running performance.Int J Sports Nutr 1998; 8: 95–104Google Scholar
  33. 33.
    Medbø JI, Mohn AC, Tabata I, et al. Anaerobic capacity determined by maximal accumulated O2 deficit. J Appl Physiol 1988; 64: 50–60PubMedGoogle Scholar
  34. 34.
    Bangsbo J. Oxygen deficit: a measure of the anaerobic energy production during intense exercise? Can J Appl Physiol 1996; 21: 350–63PubMedCrossRefGoogle Scholar
  35. 35.
    Green S, Dawson BT. The oxygen power uptake regression in cyclist and untrained men: implications foraccumulated oxygen deficit. Eur J Appl Physiol 1995; 70: 351–9CrossRefGoogle Scholar
  36. 36.
    Doherty M, Smith PM, Davison RCR, et al. Caffeine is ergogenic following supplementation of oral creatinemonohydrate. Med Sci Sports Exerc 2002; 34: 1785–92PubMedCrossRefGoogle Scholar
  37. 37.
    Vandenberghe K, Gillis N, Van Leemputte M, et al. Caffeine counteracts the ergogenic action of creatine loading. J Appl Physiol 1996; 80: 452–7PubMedGoogle Scholar
  38. 38.
    Hespel P, Op’t Eijnde B, Van Leemputte M. Opposite actions of caffeine and creatine on muscle relaxation time inhumans. J Appl Physiol 2002; 92: 513–8PubMedGoogle Scholar
  39. 39.
    Doherty M, Smith PS, Hughes MG, et al. Caffeine lowers perceptual response and increases power output duringhigh-intensity cycling. J Sports Sci 2004; 22: 637–43PubMedCrossRefGoogle Scholar
  40. 40.
    Wiles JD, Coleman D, Tegerdine M, et al. The effects of caffeine ingestion on performance time, speed and powerduring a laboratory-based 1km cycling time-trial. J Sports Sci 2006; 24: 1165–71PubMedCrossRefGoogle Scholar
  41. 41.
    Crowe MJ, Leicht AS, Spinks WL. Physiological and cognitive responses to caffeine during repeated, high-intensityexercise. Int J Sports Nutr Exerc Metab 2006; 16: 528–44Google Scholar
  42. 42.
    Green JM, Wickwire JP, McLester JR, et al. Effects of caffeine on repetitions to failure and rating of perceivedexertion during resistance training. Int J Sport Phys Per 2007; 2: 250–9Google Scholar
  43. 43.
    Hudson GM, Green MJ, Bishop PA, et al. Effects of caffeine and aspirin on resistance training performance, RPE and pain perception. Med Sci Sports Exerc 2007; 39: S248CrossRefGoogle Scholar
  44. 44.
    Williams AD, Cribb PJ, Cooke MB, et al. The effect of ephedra and caffeine on maximal strength and power inresistance-trained athletes. J Strength Cond Res 2008; 22 (6): 1950–7CrossRefGoogle Scholar
  45. 45.
    Astorino TA, Rohmann RL, Firth K. Effect of caffeine ingestion on one-repetition maximum muscular strength. Eur J Appl Physiol 2008; 102: 127–32PubMedCrossRefGoogle Scholar
  46. 46.
    Jacobs I, Pasternak H, Bell DA. Effects of ephedrine, caffeine and their combination on muscular endurance. Med Sci Sports Exerc 2003; 35: 987–94PubMedCrossRefGoogle Scholar
  47. 47.
    Bond V, Gresham K, McRae J, et al. Caffeine ingestion and isokinetic strength. Br J Sports Med 1986; 20: 135–7PubMedCrossRefGoogle Scholar
  48. 48.
    Kreighbaum E, Barthels KM. Biomechanics: a qualitative approach for studying human movement. 4th ed. NeedhamHeights (MA): Simon & Schuster Company, 1996: 562–72Google Scholar
  49. 49.
    Jacobson BH, Edwards SW. Influence of two levels of caffeine on maximal torque at selected angular velocities. Sports Med Phys Fitness 1991; 31: 147–53Google Scholar
  50. 50.
    Jacobson BH, Weber MD, Claypool L, et al. Effects of caffeine on maximal strength and power in elite maleathletes. Br J Sports Med 1992; 26: 276–80PubMedCrossRefGoogle Scholar
  51. 51.
    Williams JH, Barnes WS, Gadberry WL. Influence of caffeine on force and EMG in rested and fatigued muscle. Am J Phys Med 1987; 66: 169–83PubMedGoogle Scholar
  52. 52.
    Lopes JM, Aubier M, Jardim J, et al. Effect of caffeine on skeletal muscle function before and after fatigue. J Appl Physiol 1983; 54: 1303–5PubMedGoogle Scholar
  53. 53.
    Plaskett CJ, Cafarelli E. Caffeine increases endurance and attenuates force sensation during submaximal isometriccontractions. J Appl Physiol 2001; 91: 1535–44PubMedGoogle Scholar
  54. 54.
    Meyers BM, Cafarelli E. Caffeine increases time to fatigue by maintaining force and not by altering firing rates duringsubmaximal isometric contractions. J Appl Physiol 2005; 99: 1056–63PubMedCrossRefGoogle Scholar
  55. 55.
    Kalmar JM, Cafarelli E. Effects of caffeine on neuromuscular function. J Appl Physiol 1999; 87: 801–8PubMedGoogle Scholar
  56. 56.
    Maridakis V, O’Connor PJ, Dudley GA, et al. Caffeine attenuates delayed-onset muscle pain and force loss followingeccentric exercise. J Pain 2007; 8: 237–43PubMedCrossRefGoogle Scholar
  57. 57.
    Tarnopolsky M, Cupido C. Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitualcaffeine consumers. J Appl Physiol 2000; 89: 1719–24PubMedGoogle Scholar
  58. 58.
    McLellan TM, Bell DG. The impact of prior coffee consumption on the subsequent ergogenic effect of anhydrouscaffeine. Int J Sport Nutr Exerc Metab 2004; 14: 698–708PubMedGoogle Scholar
  59. 59.
    Dodd SL, Brooks E, Powers SK, et al. The effects of caffeine on graded exercise performance in caffeine naïve versus habituated subjects. Eur J Appl Physiol Occup Physiol 1991; 62: 424–9PubMedCrossRefGoogle Scholar
  60. 60.
    Wiles JD, Bird SR, Hopkins J, et al. Effect of caffeinated coffee on running speed, respiratory factors, blood lactateand perceived exertion during 1500-m treadmill running. Br J Sports Med 1992; 26: 116–20PubMedCrossRefGoogle Scholar
  61. 61.
    Bell DG, Jacobs I, Zamecnik J. Effects of caffeine, ephedrine and their combination on time to exhaustion duringhigh-intensity exercise. Eur J Appl Physiol 1998; 77: 427–33CrossRefGoogle Scholar
  62. 62.
    Costill DL, Dalskv GP, Fink WJ. Effects of caffeine on metabolism and exercise performance. Med Sci Sports Exerc 1978; 10: 155–8Google Scholar
  63. 63.
    Greer F, Friars D, Graham TE. Comparison of caffeine and theophylline ingestion: exercise metabolism and endurance. J Appl Physiol 2000; 89: 1837–44PubMedGoogle Scholar
  64. 64.
    Graham TE, Spriet LL. Performance and metabolic responses to a high caffeine dose during prolonged exercise. J Appl Physiol 1991; 71: 2292–8PubMedGoogle Scholar
  65. 65.
    Graham TE, Spriet LL. Metabolic, catecholamine, and exercise performance responses to various doses of caffeine. J Appl Physiol 1995; 78: 876–4CrossRefGoogle Scholar
  66. 66.
    Wemple RD, Lamb DR, McKeever KH. Caffeine vs caffeine free sports drinks: effects of urine production at restand during prolonged exercise. Int J Sports Med 1997; 18: 40–6PubMedCrossRefGoogle Scholar
  67. 67.
    Tarnopolsky MA, Atkinson SA, MacDougall JD, et al. Physiological responses to caffeine during endurancerunning in habitual caffeine users. Med Sci Sports Exerc 1989; 21: 418–24PubMedGoogle Scholar
  68. 68.
    Anderson DE, Hickey MS. Effects of caffeine on the metabolic and catecholamine responses to exercise in 5 and28 degrees C. Med Sci Sports Exerc 1994; 26: 453–8PubMedGoogle Scholar
  69. 69.
    Chesley A, Howlett RA, Heigenhauset JF, et al. Regulation of muscle glycogenolytic flux during intense aerobic exerciseafter caffeine ingestion. Am J Physiol 1998; 275: R596–603Google Scholar
  70. 70.
    Engles HJ, Haymes EM. Effects of caffeine ingestion on metabolic responses to prolonged walking in sedentarymales. Int J Sport Nutr 1992; 2: 386–96Google Scholar
  71. 71.
    Spriet LL, MacLean DA, Dyck DJ, et al. Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am J Physiol 1992; 262: E891–8Google Scholar
  72. 72.
    Hetzler RK, Warhaftig-Glynn N, Thompson DL, et al. Effects of acute caffeine withdrawal on habituated malerunners. J Appl Physiol 1994; 76: 1043–8PubMedGoogle Scholar
  73. 73.
    Graham TE, Helge JW, MacLean DA, et al. Caffeine ingestion does not alter carbohydrate or fat metabolism inhuman skeletal muscle during exercise. J Physiol 2000; 529: 837–47PubMedCrossRefGoogle Scholar
  74. 74.
    Calles J, Cunningham JJ, Nelson L, et al. Glucose turnover during recovery from intense exercise. Diabetes 1983; 32: 734–8PubMedGoogle Scholar
  75. 75.
    Cooper DM, Barstow TJ, Bergner A, et al. Blood glucose turnover during high and low intensity exercise. Am J Physiol 1989; 257: E405–12Google Scholar
  76. 76.
    Sigal RJ, Fisher SF, Halter JB, et al. The roles of catecholamines in glucoregulation in intense exercise as definedby the islet cell clamp technique. Diabetes 1996; 45: 148–56PubMedCrossRefGoogle Scholar
  77. 77.
    MacIntosh BR, Wright BM. Caffeine ingestion and performance of a 1 500-meter swim. Can J Appl Physiol 1995; 20: 168–77PubMedCrossRefGoogle Scholar
  78. 78.
    Van Soeren MH, Graham TE. Effect of caffeine on metabolism, exercise endurance, and catecholamine responsesafter withdrawal. J Appl Physiol 1998; 85: 1493–501PubMedGoogle Scholar
  79. 79.
    Lindinger MI, Williams RG, Hawke TJ. Stimulation of Na+, K+ pump activity in skeletal muscle by methylxanthines:evidence and proposed mechanisms. Acta Physiol Scand 1996; 156: 347–53PubMedCrossRefGoogle Scholar
  80. 80.
    Lindinger MI, Graham TE, Spriet LL. Caffeine attenuates the exercise-induced increase in plasma [K+] in humans. J Appl Physiol 1993; 74: 1149–55PubMedGoogle Scholar
  81. 81.
    Sjogaard G. Exercise induced muscle fatigue: the significance of potassium. Acta Physiol Scand 1990; 140: 1–63CrossRefGoogle Scholar
  82. 82.
    Lindinger MI, Sjogaard G. Potassium regulation during exercise and recovery. Sports Med 1991; 11: 382–401PubMedCrossRefGoogle Scholar
  83. 83.
    Renaud JM. Modulation of force development by Na+, K+, Na+ K+ pump, and KATP channel during muscular activity. Can J Appl Physiol 2002; 27: 296–315PubMedCrossRefGoogle Scholar
  84. 84.
    Clausen T. Long and short-term regulation of Na+-K+ pump in skeletal muscle. News Physiol Sci 1996; 11: 24–30Google Scholar
  85. 85.
    Hawks TJ, Willmets RG, Lindinger MI. K+ transport in resting hind-limb skeletal muscle in response toparaxanthine, a caffeine metabolite. Can J Physiol Pharmacol 1999; 77: 835–43Google Scholar
  86. 86.
    Lindinger MI. Potassium regulation during exercise and recovery in humans: implications for skeletal and cardiacmuscle. J Mol Cell Cardiol 1995; 27: 1011–22PubMedCrossRefGoogle Scholar
  87. 87.
    Butcher RW. Adenosine 30,50-phosphate in biological materials: I. Purification and properties of cyclic 30,50-nucleotide phosphodiesterase and use of this enzyme tocharacterize adenosine 30,50-phosphate in human urine. J Biol Chem 1963; 237: 1244–50Google Scholar
  88. 88.
    Magkos F, Kavouras ST. Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. Crit Rev Food Sci Nutr 2005; 45: 535–62PubMedCrossRefGoogle Scholar
  89. 89.
    Fain JN, Pointer RH, Ward WF. Effects of adenosine nucleoside on adenylate cyclase, phosphodiesterase, cyclicadenosine monophosphate accumulation, and lipolysis infat cells. J Biol Chem 1972; 247: 6866–72PubMedGoogle Scholar
  90. 90.
    Butcher RW. The role of cyclic AMP in the actions of some lipolytic and anti-lipolytic agents. Horm Metab Res 1970; 2: 5–10PubMedGoogle Scholar
  91. 91.
    Weber A, Herz R. The relationship between caffeine contracture of intact muscle and the effect of caffeine onreticulum. Gen Physiol 1968; 52: 750–9CrossRefGoogle Scholar
  92. 92.
    Weber A. The mechanism of the action of caffeine on sarcoplasmic reticulum. Gen Physiol 1968; 52: 760–72CrossRefGoogle Scholar
  93. 93.
    Rousseau E, LaDine J, Liu QY, et al. Activation of the Ca2+ release channel of skeletal muscle sarcoplasmicreticulum by caffeine and related compounds. Arch Biochem Biophys 1988; 267: 75–86PubMedCrossRefGoogle Scholar
  94. 94.
    Ligeti L, Batkai S, Ivanies T, et al. Caffeine induced free calcium changes in intact fast and slow twitch muscles[abstract]. FASEB J 1998; 12: A1030Google Scholar
  95. 95.
    Misumoto H, DeBoer GE, Bunge G, et al. Fiber-type specific caffeine sensitivities in normal human skeletal musclefibers. Anesthesiology 1990; 72: 50–4CrossRefGoogle Scholar
  96. 96.
    Fryer MW, Neering LR. Actions of caffeine on fast and slow-twitch muscles of the rat. J Physiol 1989; 416: 435–54PubMedGoogle Scholar
  97. 97.
    Salviati G, Volpe P. Ca+ release from sarcoplasmic reticulum of skinned fast and slow twitch muscle fibers. Am J Physiol 1988; 254: C459–65Google Scholar
  98. 98.
    Kalmar JM. The influence of caffeine on voluntary muscle activation. Med Sci Sports Exerc 2005; 12: 2113–9Google Scholar
  99. 99.
    Garret BE, Griffiths RR. The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol Biochem Behav 1997; 53: 533–41CrossRefGoogle Scholar
  100. 100.
    Fredholm BB, Battig K, Holmen J, et al. Actions of caffeine in the brain with special reference to factors that contributeto its widespread use. Pharmacol Rev 1999; 51: 84–113Google Scholar
  101. 101.
    Okada M, Kiryu K, Kawata Y, et al. Determination of the effects of caffeine and carbamazepine on striatal dopaminerelease by in vivo microdialysis. Eur J Pharmacol 1997; 321: 181–8PubMedCrossRefGoogle Scholar
  102. 102.
    Swynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998; 347: 1–11CrossRefGoogle Scholar
  103. 103.
    Fredholm BB. Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol Sci 1980; 1: 129–32CrossRefGoogle Scholar
  104. 104.
    Fredholm BB. Adenosine, adenosine receptors, and the actions of caffeine. Pharmacol Toxicol 1995; 76: 93–101PubMedCrossRefGoogle Scholar
  105. 105.
    Fredholm BB. On the mechanism of action of theophylline and caffeine. Acta Med Scand 1985; 217: 149–53PubMedCrossRefGoogle Scholar
  106. 106.
    Rall TW. The 1982 Theodore Weicker Memorial Award Oration: evolution of the mechanism of methylxanthines – from calcium mobilizers to antagonists of adenosinereceptors. Pharmacologist 1982; 24: 277–87Google Scholar
  107. 107.
    Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 2001; 79: 463–84PubMedCrossRefGoogle Scholar
  108. 108.
    Costa F, Diedrich A, Johnson B, et al. Adenosine, a metabolic trigger of the exercise pressor reflex in humans. Hypertension 2001; 37: 917–22PubMedCrossRefGoogle Scholar
  109. 109.
    Daly JW. Adenosine receptors: targets for future drugs. J Med Chem 1982; 25: 197–207PubMedCrossRefGoogle Scholar
  110. 110.
    Abreu A, Mahmarian JJ, Nishimura S, et al. Tolerance and safety of pharmacologic coronary vasodilation with adenosinein association with thalium-201 scintigraphy inpatients with suspected coronary artery disease. J Am Coll Cardiol 1991; 18: 730–5PubMedCrossRefGoogle Scholar
  111. 111.
    Sylvan C, Jonzono B, Fredholm BB, et al. Adenosine injection into the brachial artery produces ischaemia like painor discomfort in the forearm. Cardiovasc Res 1988; 22: 674–8CrossRefGoogle Scholar
  112. 112.
    Porkka-Heiskanen T. Adenosine in sleep and wakefulness. Ann Med 1991; 31: 125–9CrossRefGoogle Scholar
  113. 113.
    Huston JP, Haas HI, Boix F, et al. Extracellular adenosine levels in neostriatum and hippocampus during rest andactivity periods of rats. Neuroscience 1996; 73: 99–107PubMedCrossRefGoogle Scholar
  114. 114.
    Barraco RA, Coffin VL, Altman HJ, et al. Central effects of adenosine analogs on locomotor activity in mice andantagonism of caffeine. Brain Res 1983; 272: 392–5PubMedCrossRefGoogle Scholar
  115. 115.
    Dunwiddie TV. The physiological role of adenosine in the central nervous system. Int Rev Neurol 1985; 27: 63–139CrossRefGoogle Scholar
  116. 116.
    Stone TW, Newby AC, Lloyd HE. Adenosine release. In: Williams M, editor. Adenosine and adenosine receptors. Humana Press (NJ), 1990: 173–223CrossRefGoogle Scholar
  117. 117.
    Williams M. Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol 1987; 27: 315–45PubMedCrossRefGoogle Scholar
  118. 118.
    Harms HH, Wardeh G, Mulder AH. Adenosine modulates depolarization-induced release of 5’N-ethylcarboxamidoadenosine3H-noradrenaline from slices of rat brainneocortex. Eur J Pharmacol 1978; 49: 305–8PubMedCrossRefGoogle Scholar
  119. 119.
    Gervitz LM, Luthere LO, Davies DG, et al. Adenosine induces initial hypoxic-ischemic depression of synaptictransmission in the rat hippocampus in vivo. Am J Physiol Regul Integr Comp Physiol 2001; 280: R639–45Google Scholar
  120. 120.
    Olah ME, Stiles GL. Adenosine receptor subtypes characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 1995; 35: 581–606PubMedCrossRefGoogle Scholar
  121. 121.
    Fredholm BB, Abbracchio MP, Burnstock F, et al. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994; 46: 143–56PubMedGoogle Scholar
  122. 122.
    McCall AL, Millington WR, Wurtman RJ. Blood-brain barrier transport of caffeine: dose-related restriction ofadenine transport. Life Sci 1982; 31: 2709–15PubMedCrossRefGoogle Scholar
  123. 123.
    Reddington M, Lee KS. Adenosine receptor subtypes: classification and distribution. In: Stone TW, editors. Adenosinein the nervous system. London: Academic Press, 1991: 77CrossRefGoogle Scholar
  124. 124.
    Lund JP, Donga R, Widemer C, et al. The pain-adaptation model: a discussion of the relationship between chronicmusculoskeletal pain and motor activity. Can J Physiol Pharmacol 1991; 69: 683–94PubMedCrossRefGoogle Scholar
  125. 125.
    Farina D, Arendt-Nielsen L, Merletti R, et al. Effect of experimental muscle pain on motor unit firing rate andconduction velocity. J Neurophysiol 2004; 91: 1250–9PubMedCrossRefGoogle Scholar
  126. 126.
    Sohn KM, Graves-Nielsen T, Arendt-Nielsen L, et al. Inhibition of motor unit firing during experimental musclepain in humans. Muscle Nerve 2000; 23: 1219–26PubMedCrossRefGoogle Scholar
  127. 127.
    Kellgren JH. Observations on referred pain arising from muscle. Clin Sci 1938; 38: 175–90Google Scholar
  128. 128.
    Lewis T. Suggestions relating to the study of somatic pain. Br Med J 1938; 12: 321–5CrossRefGoogle Scholar
  129. 129.
    Stohler CS, Lund JP. Effects of noxious stimulation of the jaw muscle on the sensory experience of volunteer humansubjects. In: Stohler CS, Carlson DS, editors. Biologicaland psychological aspects of orofacial pain. Ann Arbor(MI): University of Michigan, 1994: 53–73Google Scholar
  130. 130.
    Svensson P, Arendt-Nielsen L, Houe L. Sensory-motor interactions of human experimental unilateral jaw musclepain: a quantitative analysis. Pain 1996; 64: 241–9PubMedCrossRefGoogle Scholar
  131. 131.
    Gaspardone A, Crea F, Tomai F, et al. Substance P potentiates the algogenic effects of intraarterial infusion ofadenosine. J Am Coll Cardiol 1994; 24: 477–82PubMedCrossRefGoogle Scholar
  132. 132.
    Sylvan C, Beermann B, Jonzon B, et al. Angina pectorislike pain provoked by intravenous adenosine in healthyvolunteers. Br Med J Clin Res Ed 1986; 293: 227–30CrossRefGoogle Scholar
  133. 133.
    Pappagallo M, Gaspardone A, Tomai F, et al. Analgesic effect of bamiphylline on pain induced by intradermalinjection of adenosine. Pain 1993; 43: 199–204CrossRefGoogle Scholar
  134. 134.
    Taiwo Yo, Levine JD. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 1990; 38: 757–62PubMedCrossRefGoogle Scholar
  135. 135.
    Karlsten R, Gordh T, Post C. Local antinociceptive and hyper-algesic effects in the formalin test after peripheraladministration of adenosine analogues in mice. Pharmacol Toxicol 1992; 70: 434–8PubMedCrossRefGoogle Scholar
  136. 136.
    Doak GY, Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur J Pharmacol 1995; 281: 311-8PubMedCrossRefGoogle Scholar
  137. 137.
    Ferré S, Diamond I, Goldberg SR, et al. Adenosine A(2A) receptors in ventral stratum, hypothalamus and nociceptivecircuitry implications for drug addiction, sleep andpain. Prog Neurobiol 2007; 83 (5): 332–47PubMedCrossRefGoogle Scholar
  138. 138.
    Popoli P, Blum D, Martire A, et al. Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington’s disease. Prog Neurobiol 2007; 81: 331–48PubMedCrossRefGoogle Scholar
  139. 139.
    Bonucelli U, DelDotto P. Newpharmacologic horizons in the treatment of Parkinson disease. Neurology 2006; 67: S30–8CrossRefGoogle Scholar
  140. 140.
    Mense S. Group III and IV receptors in skeletal muscle: are they specific or polymodal? Prog Brain Res 1996; 113: 83–100PubMedCrossRefGoogle Scholar
  141. 141.
    Mitchell JH, Kaufman MP, Iwamoto GA. The exercise pressor reflex: its cardiovascular effects, afferentmechanisms,and central pathways. Ann Rev Physiol 1983; 45: 229–42CrossRefGoogle Scholar
  142. 142.
    Laska EM, Sunshine A, Mueller F, et al. Caffeine as an analgesic adjuvant. JAMA 1983; 25: 1711–8Google Scholar
  143. 143.
    Schachtel BP, Thoden WR, Konerman JP, et al. Headache pain model for assessing and comparing the efficacy ofover-the-counter analgesic agents. Clin Pharmacol Ther 1991; 50: 322–9PubMedCrossRefGoogle Scholar
  144. 144.
    Migliardi JR, Armellino JJ, Friedman M, et al. Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994; 56: 576–86PubMedCrossRefGoogle Scholar
  145. 145.
    Myers DA, Shaikh Z, Zullo TG. Hypoalgesic effect of caffeine in experimental ischemic muscle contraction pain. Headache 1997; 37: 654–8PubMedCrossRefGoogle Scholar
  146. 146.
    Motl RW, O’Connor PJ, Dishman RK. Effects of caffeine on perceptions of leg muscle pain during moderate intensitycycling exercise. J Pain 2003; 4: 316–21PubMedCrossRefGoogle Scholar
  147. 147.
    O’Connor PJ, Motl RW, Broglio SP, et al. Dose-dependent effect of caffeine on reducing leg muscle pain during cyclingexercise is unrelated to systolic blood pressure. Pain 2004; 109: 291–8PubMedCrossRefGoogle Scholar
  148. 148.
    Motl RW, O’Connor PJ, Tubandt L, et al. Effect of caffeine on leg muscle pain during cycling exercise amongfemales. Med Sci Sports Exerc 2006; 38: 598–604PubMedCrossRefGoogle Scholar
  149. 149.
    Cook DB, O’Connor PJ, Oliver SE, et al. Naturally occurring muscle pain during exercise: assessment and experimentalevidence. Med Sci Sports Exerc 1997; 29: 999–1012PubMedCrossRefGoogle Scholar
  150. 150.
    Hong-You GE, Arendt-Nielsen L, Farina D, et al. Genderspecific differences in electromyographic changes in perceivedpain induced by experimental muscle pain duringsustained contractions of the upper trapezius muscle. Muscle Nerve 2005; 32: 726–33CrossRefGoogle Scholar
  151. 151.
    Dao TT, LeResche L. Gender differences in pain. J Orofac Pain 2000; 14: 169–84PubMedGoogle Scholar
  152. 152.
    Mohr T, Van Soeren M, Graham TE, et al. Caffeine ingestion and metabolic responses of tetraplegic humansduring electrical cycling. J Appl Physiol 1998; 85: 979–85PubMedGoogle Scholar
  153. 153.
    Cole KJ, Costill DL, Starling RD, et al. Effect of caffeine ingestion on perception of effort and subsequent workproduction. Int J Sports Nutr 1996; 6: 14–23Google Scholar
  154. 154.
    Spriet LL, Howlett RA. Caffeine. In: Maughan RJ, editor. Nutrition in sport. Oxford: Blackwell Scientific, 2000: 379–92CrossRefGoogle Scholar
  155. 155.
    Kalmar JM, Cafarelli E. Caffeine: a valuable tool to study central fatigue in humans? Exerc Sport Sci Rev 2004; 32: 143–7PubMedCrossRefGoogle Scholar
  156. 156.
    Pasma WJ, Van Baak MA, Jeukendrup AE, et al. The effects of different dosages of caffeine on endurance performancetime. Int J Sports Med 1995; 16: 225–30CrossRefGoogle Scholar
  157. 157.
    Davis MJ, Zuowei Z, Stock HS, et al. Central nervous system effects of caffeine and adenosine on fatigue. Am J Physiol Regul Integr Comp Physiol 2002; 284: 399–408Google Scholar

Copyright information

© Springer International Publishing AG 2009

Authors and Affiliations

  1. 1.Department of Health and Human PerformanceTexas A &M University-CommerceCommerceUSA
  2. 2.Department of Health, Physical Education and RecreationUniversity of North AlabamaFlorenceUSA

Personalised recommendations